ID: ALA2114211

Max Phase: Preclinical

Molecular Formula: C34H47NO4

Molecular Weight: 533.75

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C1/C(=C/C=C2/CCC[C@@]3(C)C2CCC3[C@H](C)C[C@@H]2C[C@@](C)(O)C(=O)N2Cc2ccccc2)C[C@@H](O)C[C@@H]1O

Standard InChI:  InChI=1S/C34H47NO4/c1-22(17-27-20-34(4,39)32(38)35(27)21-24-9-6-5-7-10-24)29-14-15-30-25(11-8-16-33(29,30)3)12-13-26-18-28(36)19-31(37)23(26)2/h5-7,9-10,12-13,22,27-31,36-37,39H,2,8,11,14-21H2,1,3-4H3/b25-12-,26-13+/t22-,27-,28-,29?,30?,31+,33-,34-/m1/s1

Standard InChI Key:  NZGHXKMUEBZPLG-AOJXDVDGSA-N

Associated Targets(non-human)

Vitamin D receptor 183 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 533.75Molecular Weight (Monoisotopic): 533.3505AlogP: 5.71#Rotatable Bonds: 6
Polar Surface Area: 81.00Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.97CX Basic pKa: CX LogP: 4.20CX LogD: 4.20
Aromatic Rings: 1Heavy Atoms: 39QED Weighted: 0.44Np Likeness Score: 1.69

References

1. Kato Y, Nakano Y, Sano H, Tanatani A, Kobayashi H, Shimazawa R, Koshino H, Hashimoto Y, Nagasawa K..  (2004)  Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.,  14  (10): [PMID:15109656] [10.1016/s0960-894x(04)00294-x]

Source